Nick DeLong
Corporate Officer/Principal presso IBIO, INC.
Profilo
Nick DeLong is the founder of Evolved Capital, Inc. He currently holds the position of Vice President-Corporate Development at iBio, Inc. Previously, he worked as Head-Business Development at Tris Pharma, Inc. Dr. DeLong holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Rutgers University-Newark.
Posizioni attive di Nick DeLong
| Società | Posizione | Inizio |
|---|---|---|
| IBIO, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Nick DeLong
| Società | Posizione | Fine |
|---|---|---|
| Evolved Capital, Inc. | Fondatore | - |
Tris Pharma, Inc.
 Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Corporate Officer/Principal | - |
Formazione di Nick DeLong
| University of Pennsylvania | Doctorate Degree |
| Rutgers University- Newark | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IBIO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Tris Pharma, Inc. engages in the provision of specialty pharmaceutical cervices. It focuses on the development of pharmaceutical science and technology-based products. The company was founded by Ketan Mehta in 2000 and is headquartered in Monmouth Junction, NJ. | Health Technology |
| Evolved Capital, Inc. | Technology Services |
- Borsa valori
- Insiders
- Nick DeLong
